B7-H1-targeted immunotherapy for head and neck cancer.

about

B7-H1 limits the entry of effector CD8(+) T cells to the memory pool by upregulating Bim

P2860

Q36388507-C92A2010-AE42-4B56-A362-8A925C3929C5

P2860

B7-H1-targeted immunotherapy for head and neck cancer.

Item

http://www.wikidata.org/entity/Q35907010

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

B7-H1-targeted immunotherapy for head and neck cancer.

@ast

B7-H1-targeted immunotherapy for head and neck cancer.

@en

type

Item

label

B7-H1-targeted immunotherapy for head and neck cancer.

@ast

B7-H1-targeted immunotherapy for head and neck cancer.

@en

prefLabel

B7-H1-targeted immunotherapy for head and neck cancer.

@ast

B7-H1-targeted immunotherapy for head and neck cancer.

@en

P1476

B7-H1-targeted immunotherapy for head and neck cancer.

@en

P2093

Scott E Strome

http://www.w3.org/2001/XMLSchema#string

Xiaoyu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

CD28/B7 system of T cell costimulation

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

P304

1577-1583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.4.10.1577

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15461569

http://www.w3.org/2001/XMLSchema#string

B7-H1-targeted immunotherapy for head and neck cancer.

about

P2860

P2860

B7-H1-targeted immunotherapy for head and neck cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698